IgG糖基化依赖的CLEC7A信号驱动狼疮肾炎足细胞功能障碍
该研究探讨狼疮肾炎(LN)患者IgG通过CLEC7A识别岩藻糖并激活SYK导致足细胞损伤的机制。体外实验显示LN-IgG而非健康对照或无肾炎SLE患者IgG可增加足细胞CLEC7A表达、破坏细胞骨架、降低nephrin并损害运动能力,去糖基化可阻断该效应;药理性抑制SYK或沉默CLEC7A可预防足细胞损伤。
要点
- LN-IgG通过CLEC7A-SYK轴损伤足细胞,去糖基化可阻断结合并保护功能。
- 活动性LN患者肾活检和MRL/lpr小鼠足细胞CLEC7A与SYK表达升高。
- 抑制SYK或沉默CLEC7A可预防LN-IgG诱导的足细胞损伤。
核心结论
- 研究揭示IgG-凝集素-糖基-CLEC7A-SYK轴参与LN发病,可作为治疗靶点。
研究设计与样本
- 将活动性LN患者及健康对照的IgG暴露于分化的人足细胞,采用qPCR、Western blot、免疫荧光、鬼笔环肽染色、钙流和伤口愈合实验评估反应。
- 检查人肾活检和MRL/lpr小鼠肾脏以验证CLEC7A-SYK通路激活及LN-IgG的糖基依赖效应。
主要发现
- 人足细胞暴露于CLEC7A配体curdlan或LN-IgG后CLEC7A表达增加、运动受损、细胞骨架破坏、nephrin表达降低,而健康对照IgG或无肾炎SLE患者IgG无此效应。
- LN-IgG去糖基化可阻断CLEC7A结合并保护足细胞功能。
- curdlan和LN-IgG增加钙流并激活SYK。
- MRL/lpr肾炎小鼠足细胞CLEC7A和SYK表达升高。
- 活动性LN患者肾活检足细胞SYK和CLEC7A表达较健康对照增加。
关键数值与推荐
- 药理性抑制SYK或沉默CLEC7A可预防足细胞损伤。
临床怎么用
- 提示靶向CLEC7A-SYK轴或干预IgG糖基化可能成为LN治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus (SLE) that can lead to end-stage kidney disease and increased mortality. IgG from patients with LN displays abnormal glycosylation, contributing to podocyte injury. CLEC7A (C-type lectin domain family 7 member A) is a transmembrane lectin receptor that recognizes fucose on IgG. This study investigates the role of lectin-glycan interactions in LN-related podocyte dysfunction. METHODS: IgG isolated from patients with active LN and healthy controls was exposed to differentiated human podocytes. Gene and protein responses were assessed by quantitative polymerase chain reaction, Western blotting, immunofluorescence, phalloidin staining, calcium flux, and wound-healing assays. Human kidney biopsies and MRL/lpr mouse kidneys were examined to validate CLEC7A-spleen tyrosine kinase (SYK) pathway activation and the glycan-dependent effects of LN-IgG. RESULTS: Human podocytes exposed to the CLEC7A ligand curdlan or LN-IgG, but not healthy control IgG or IgG from patients with SLE without nephritis, showed increased CLEC7A expression, impaired motility, cytoskeleton disruption, and reduced nephrin expression. Deglycosylation of LN-IgG blocked CLEC7A binding and preserved podocyte function. Mechanistically, curdlan and LN-IgG increased calcium flux and activated SYK. MRL/lpr mice with nephritis exhibited elevated podocyte CLEC7A and SYK expression. Similarly, podocytes in kidney biopsies from patients with active LN exhibit increased expression of SYK and CLEC7A compared with healthy controls. Pharmacological SYK inhibition or CLEC7A silencing prevented podocyte injury. CONCLUSION: We reveal a novel IgG lectin-glycan-CLEC7A-SYK axis involved in the pathogenesis of LN, which can be targeted therapeutically in patients with LN.
引用
- Upadhyay R, Orellana A, Tsokos GC, et al. IgG Glycosylation-Dependent CLEC7A Signaling Drives Podocyte Dysfunction in Lupus Nephritis. Arthritis Rheumatol. 2026. PMID: 42328892. doi:10.1002/art.70260
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。